Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 4
2012 4
2013 2
2014 4
2015 10
2016 3
2017 4
2018 6
2019 7
2020 8
2021 5
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY, Psimaras D, Alentorn A. Dade M, et al. Among authors: alentorn a. Int J Mol Sci. 2020 May 24;21(10):3701. doi: 10.3390/ijms21103701. Int J Mol Sci. 2020. PMID: 32456344 Free PMC article. Review.
Mechanisms and therapeutic implications of hypermutation in gliomas.
Touat M, Li YY, Boynton AN, Spurr LF, Iorgulescu JB, Bohrson CL, Cortes-Ciriano I, Birzu C, Geduldig JE, Pelton K, Lim-Fat MJ, Pal S, Ferrer-Luna R, Ramkissoon SH, Dubois F, Bellamy C, Currimjee N, Bonardi J, Qian K, Ho P, Malinowski S, Taquet L, Jones RE, Shetty A, Chow KH, Sharaf R, Pavlick D, Albacker LA, Younan N, Baldini C, Verreault M, Giry M, Guillerm E, Ammari S, Beuvon F, Mokhtari K, Alentorn A, Dehais C, Houillier C, Laigle-Donadey F, Psimaras D, Lee EQ, Nayak L, McFaline-Figueroa JR, Carpentier A, Cornu P, Capelle L, Mathon B, Barnholtz-Sloan JS, Chakravarti A, Bi WL, Chiocca EA, Fehnel KP, Alexandrescu S, Chi SN, Haas-Kogan D, Batchelor TT, Frampton GM, Alexander BM, Huang RY, Ligon AH, Coulet F, Delattre JY, Hoang-Xuan K, Meredith DM, Santagata S, Duval A, Sanson M, Cherniack AD, Wen PY, Reardon DA, Marabelle A, Park PJ, Idbaih A, Beroukhim R, Bandopadhayay P, Bielle F, Ligon KL. Touat M, et al. Among authors: alentorn a. Nature. 2020 Apr;580(7804):517-523. doi: 10.1038/s41586-020-2209-9. Epub 2020 Apr 15. Nature. 2020. PMID: 32322066 Free PMC article.
Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
Houillier C, Soussain C, Ghesquières H, Soubeyran P, Chinot O, Taillandier L, Lamy T, Choquet S, Ahle G, Damaj G, Agapé P, Moluçon-Chabrot C, Amiel A, Delwail V, Fabbro M, Jardin F, Chauchet A, Moles-Moreau MP, Morschhauser F, Casasnovas O, Gressin R, Fornecker LM, Abraham J, Marolleau JP, Tempescul A, Campello C, Colin P, Tamburini J, Laribi K, Serrier C, Haioun C, Chebrek S, Schmitt A, Blonski M, Houot R, Boyle E, Bay JO, Oberic L, Tabouret E, Waultier A, Martin-Duverneuil N, Touitou V, Cassoux N, Kas A, Mokhtari K, Charlotte F, Alentorn A, Feuvret L, Le Garff-Tavernier M, Costopoulos M, Mathon B, Peyre M, Delgadillo D, Douzane H, Genet D, Aidaoui B, Hoang-Xuan K, Gyan E. Houillier C, et al. Among authors: alentorn a. Neurology. 2020 Mar 10;94(10):e1027-e1039. doi: 10.1212/WNL.0000000000008900. Epub 2020 Jan 6. Neurology. 2020. PMID: 31907289 Free PMC article.
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A, Marie Y, Mokhtari K, Tabouret E, Trabelsi N, Uro-Coste E, Delattre JY, Figarella-Branger D; POLA Network. Appay R, et al. Among authors: alentorn a. Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124. Neuro Oncol. 2019. PMID: 31832685 Free PMC article.
[Genetics and brain gliomas].
Alentorn A, Labussière M, Sanson M, Delattre JY, Hoang-Xuan K, Idbaih A. Alentorn A, et al. Presse Med. 2013 May;42(5):806-13. doi: 10.1016/j.lpm.2012.05.013. Epub 2012 Jul 11. Presse Med. 2013. PMID: 22789312 Review. French.
Presenting signs and symptoms in brain tumors.
Alentorn A, Hoang-Xuan K, Mikkelsen T. Alentorn A, et al. Handb Clin Neurol. 2016;134:19-26. doi: 10.1016/B978-0-12-802997-8.00002-5. Handb Clin Neurol. 2016. PMID: 26948346 Review.
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis.
Muñiz-Castrillo S, Haesebaert J, Thomas L, Vogrig A, Pinto AL, Picard G, Blanc C, Do LD, Joubert B, Berzero G, Psimaras D, Alentorn A, Rogemond V, Dubois V, Ambati A, Tamouza R, Mignot E, Honnorat J. Muñiz-Castrillo S, et al. Among authors: alentorn a. Neurol Neuroimmunol Neuroinflamm. 2021 Mar 5;8(3):e974. doi: 10.1212/NXI.0000000000000974. Print 2021 May. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33848259 Free PMC article.
Molecular profiling of gliomas: potential therapeutic implications.
Alentorn A, Duran-Peña A, Pingle SC, Piccioni DE, Idbaih A, Kesari S. Alentorn A, et al. Expert Rev Anticancer Ther. 2015;15(8):955-62. doi: 10.1586/14737140.2015.1062368. Epub 2015 Jun 28. Expert Rev Anticancer Ther. 2015. PMID: 26118895 Review.
SARS-CoV-2 infection in patients with primary central nervous system lymphoma.
Laurenge A, Ursu R, Houillier C, Abdi B, Tebano G, Quemeneur C, Choquet S, Di Blasi R, Lozano F, Morales A, Durán-Peña A, Sirven-Villaros L, Mathon B, Mokhtari K, Bielle F, Martin-Duverneuil N, Delattre JY, Marcelin AG, Pourcher V, Alentorn A, Idbaih A, Carpentier AF, Leblond V, Hoang-Xuan K, Touat M. Laurenge A, et al. Among authors: alentorn a. J Neurol. 2021 Sep;268(9):3072-3080. doi: 10.1007/s00415-020-10311-w. Epub 2021 Jan 2. J Neurol. 2021. PMID: 33387015 Free PMC article.
55 results